Clinical Trial Update: The Effects of Microbiological Spectrum Changes to Improve Cognitive Health in Aging Population [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating how changes in the microbiological spectrum affect cognitive health and mood in aging individuals; completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aging-related Cognitive Decline
• Cognitive Decline
• Memory Deficits
• Mood Change

Snippet

Sponsor: National Institute of Mental Health, Czech Republic | Conditions: Memory Deficits, Mood Change | Phase 2 | Status: COMPLETED